u 69593 has been researched along with butorphanol in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M | 1 |
Ho, IK; Hoshi, K; Ma, T | 1 |
Ho, IK; Hoshi, K; Ma, T; Oh, S | 1 |
DeYoung, MB; Lewis, JW; Sumpter, TL; Traynor, JR; Vivian, JA; Woods, JH | 1 |
Craft, RM; Raub, DJ; Ulibarri, CM | 1 |
French, AM; Smith, MA | 1 |
Craft, RM; McNiel, DM | 1 |
7 other study(ies) available for u 69593 and butorphanol
Article | Year |
---|---|
Effects of nor-binaltorphimine on butorphanol dependence.
Topics: Animals; Benzeneacetamides; Body Temperature; Body Weight; Butorphanol; Diarrhea; Down-Regulation; Drug Administration Schedule; Escape Reaction; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1993 |
Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus.
Topics: Analgesics; Analysis of Variance; Animals; Aspartic Acid; Benzeneacetamides; Butorphanol; Glutamic Acid; Injections, Intraventricular; Locus Coeruleus; Male; Microdialysis; Naloxone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 1996 |
Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine.
Topics: Animals; Benzeneacetamides; Butorphanol; Drug Evaluation, Preclinical; Excitatory Amino Acids; Locus Coeruleus; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Azocines; Benzeneacetamides; Butorphanol; Cinnamates; Conditioning, Operant; Discrimination Learning; Diuresis; Dose-Response Relationship, Drug; Ethylketocyclazocine; Female; Injections, Intramuscular; Macaca mulatta; Male; Morphine Derivatives; Nalbuphine; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, kappa | 1999 |
Kappa opioid-induced diuresis in female vs. male rats.
Topics: Animals; Arginine Vasopressin; Benzeneacetamides; Benzomorphans; Butorphanol; Diuresis; Female; Male; Pentazocine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sex Factors | 2000 |
Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Age Factors; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Analysis of Variance; Animals; Benzeneacetamides; Butorphanol; Cold Temperature; Dose-Response Relationship, Drug; Drug Synergism; Male; Nalbuphine; Pain; Pain Measurement; Pyrrolidines; Rats; Rats, Inbred F344; Reaction Time; Receptors, Opioid, kappa | 2002 |
Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
Topics: Animals; Benzeneacetamides; Butorphanol; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Male; Nalbuphine; Naltrexone; Narcotic Antagonists; Pentazocine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Urination | 2003 |